Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01375660 · ClinicalTrials.gov registry record · NA
D Vitamin Intervention in VA
A NA study of Impaired Glucose Tolerance and Vitamin D Insufficiency, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 205
- Enrollment target
- 1
- Study location
NCT01375660 is a NA study of Impaired Glucose Tolerance and Vitamin D Insufficiency that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 205 participants, above the 74-participant average among 13 other Impaired Glucose Tolerance trials with a reported enrollment target (177% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01375660, a NA study of Impaired Glucose Tolerance and Vitamin D Insufficiency, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 205 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will supplement African American male (AAM) veterans at risk for diabetes and newly diagnosed T2DM with vitamin D (low or higher dose) and evaluate whether vitamin D helps to improve early markers of diabetes. The study will be done at Veteran Administration Medical Center in Chicago.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG 50K vitamin D2
Study Locations (1)
Illinois
- Jesse Brown VA Medical Center, Chicago, IL - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01375660
The ClinicalTrials.gov registry entry for NCT01375660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 74-participant average among 13 other Impaired Glucose Tolerance trials with a reported enrollment target (177% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Impaired Glucose Tolerance appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01375660 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01375660 about?
NCT01375660 is a clinical study titled "D Vitamin Intervention in VA". This study will supplement African American male (AAM) veterans at risk for diabetes and newly diagnosed T2DM with vitamin D (low or higher dose) and evaluate whether vitamin D helps to improve early markers of diabetes. The study will be done at Veteran Administration Medical Center in Chicago.
What is the current status of trial NCT01375660?
This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2011-05. Estimated completion is 2014-11.
What conditions does trial NCT01375660 study?
This clinical trial studies the following conditions: Impaired Glucose Tolerance, Vitamin D Insufficiency, Impaired Fasting Glucose.
What interventions are being tested in trial NCT01375660?
The interventions under investigation include: Placebo (DRUG), 50K vitamin D2 (DRUG).
Who is sponsoring clinical trial NCT01375660?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01375660 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Impaired Glucose Tolerance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
RECRUITING · NA
-
CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance
RECRUITING · NA
-
Night Owl Metabolism
RECRUITING · NA
-
Improving Autonomic Function and Balance in Diabetic Neuropathy
ACTIVE NOT RECRUITING · NA
-
Effect of Dietary Glycemic Index on Beta-cell Function
COMPLETED · NA
-
Sucralose, Stevia, Gut Microbiome and Glucose Metabolism
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.